group of laboratory test tubes with red liquid inside

The UK government has reached a deal with drug company GlaxoSmith Kline to be the first worldwide to routinely vaccinate babies against Meningitis B.  According to an article via, “As a result Bexsero, the only licensed MenB vaccine, will now be added to the national childhood immunisation programme, with children to receive their first shot at two months of age, followed by two further doses.”  For more information on this agreement, please visit: